Variance of mean platelet volume in subjects with normal glucose tolerance, impaired glucose regulation and type 2 diabetic mellitus and its relationship with diabetic peripheral artery disease

National Medical Journal of China

Volumn 92, Issue 4, 2012, Pages 232-235

  Li, Sha ^a   Wang, Chun ^a   Zhong, Xiao Wei ^b   Li, Hua Qi ^b   Fu, Xu Quan ^b   Ran, Xing Wu ^a  

^a SICHUAN UNIVERSITY   (China)

^b NONE

Author keywords

Diabetes mellitus, type 2; Diabetic angiopathies; Platelet volume

Indexed keywords

CHOLESTEROL; CREATININE; GLUCOSE; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL; URIC ACID;

ANKLE BRACHIAL INDEX; ARTICLE; BLOOD PRESSURE MEASUREMENT; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DISEASE ASSOCIATION; GLUCOSE BLOOD LEVEL; GLUCOSE TOLERANCE; HUMAN; IMPAIRED GLUCOSE TOLERANCE; MAJOR CLINICAL STUDY; NON INSULIN DEPENDENT DIABETES MELLITUS; OBSERVATIONAL STUDY; PERIPHERAL OCCLUSIVE ARTERY DISEASE; THROMBOCYTE COUNT; THROMBOCYTE VOLUME; TRIACYLGLYCEROL BLOOD LEVEL; URIC ACID BLOOD LEVEL;

AGED; BLOOD PLATELETS; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 2; DIABETIC ANGIOPATHIES; FEMALE; HUMANS; LOWER EXTREMITY; MALE; MIDDLE AGED; PERIPHERAL ARTERIAL DISEASE; PLATELET COUNT;

EID: 84867879999     PISSN: 03762491     EISSN: None     Source Type: Journal    
DOI: 10.3760/cma.j.issn.0376-2491.2012.04.006     Document Type: Article

References (17)

1. Davì G, Patrono C. Platelet activation and atherothrombosis. N Engl J Med, 2007, 357: 2482-2494.
2. Eibl N, Krugluger W, Streit G, et al. Improved metabolic control decreases platelet activation markers in patients with type-2 diabetes. Eur J Clin Invest, 2004, 34:205-209.
3. Karpatkin S. Heterogeneity of human platelets. II. Functional evidence suggestive of young and old platelets. J Clin Invest, 1969, 48: 1083-1087.
4. Kamath S, Blann A D, Lip G Y. Platelet activation: assessment and quantification. Eur Heart J, 2001, 22: 1561-1571.
5. Bath P M, Butterworth R J. Platelet size: measurements, physiology and vascular disease. Blood Coagul Fibrinolysis, 1996, 7: 157-161.
6. Sharpe P C, Trinick T. Mean platelet volume in diabetes mellitus. Q J Med, 1993, 86: 739-742.
7. Endler G, Klimesch A, Sunder-Plassmann H, et al. Mean platelet volume is an independent risk factor for myocardial infarction but not for coronary artery disease. Br J Haematol, 2002, 117: 399-404.
8. Dalamaga M, Karmaniolas K, Lekka A, et al. Platelet markers correlate with glycemic indices in diabetic, but not diabetic-myelodysplastic patients with normal platelet count. Dis Markers, 2010, 29: 55-61.
9. Szeremeta M, Kemona-Chetnik I, Dymicka-Piekarska V, et al. The relations between platelet count, mean platelet volume and HbA1c in patients with type 2 diabetes. Przegl Lek, 2009, 66: 1049-1051.
10. Coban E, Kucuktag S, Basyigit S. Platelet activation in subjects with impaired glucose tolerance. Platelets, 2007, 18:591-594.
11. 2005, 15:343-345.
12. 2008, 28:832-835.
13. Tavil Y, Sen N, Yazici H, et al. Coronary heart disease is associated with mean platelet volume in type 2 diabetic patients. Platelets, 2010, 21:368-372.
14. Jin R C, Voetsch B, Loscalzo J. Endogenous mechanisms of inhibition of platelet function. Microcirculation, 2005, 12: 247-258.
15. Yarlioglues M, Kaya M G, Ardic I, et al. Relationship between mean platelet volume levels and subclinical target organ damage in newly diagnosed hypertensive patients. Blood Press, 2011, 20: 92-97.
16. 2010, 30: 2409-2411.
17. Berger J S, Eraso L H, Xie D, et al. Mean platelet volume and prevalence of peripheral artery disease, the National Health and Nutrition Examination Survey, 1999-2004. Atherosclerosis, 2010, 213: 586-591.